Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
Shaw, A.T., Riely, G.J., Bang, Y.-J., Kim, D.-W., Camidge, D.R., Solomon, B.J., Varella-Garcia, M., Iafrate, A.J., Shapiro, G.I., Usari, T., Wang, S.C., Wilner, K.D., Clark, J.W., Ou, S.-H.I.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
Lin, J.J., Liu, S.V., McCoach, C.E., Zhu, V.W., Tan, A.C., Yoda, S., Peterson, J., Do, A., Prutisto-Chang, K., Dagogo-Jack, I., Sequist, L.V., Wirth, L.J., Lennerz, J.K., Hata, A.N., Mino-Kenudson, M., Nardi, V., Ou, S.-H.I., Tan, D.S.-W., Gainor, J.F.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib
Oztan, A., Fischer, S., Schrock, A.B., Erlich, R.L., Lovly, C.M., Stephens, P.J., Ross, J.S., Miller, V., Ali, S.M., Ou, S.-H.I., Raez, L.E.
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2017)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2017)
Get full text
Journal Article
Updated safety and efficacy of durvalumab (MEDI4736), an anti-PD-L 1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort
Segal, N.H., Ou, S.-H.I., Balmanoukian, A.S., Massarelli, E., Brahmer, J.R., Weiss, J., Schoffski, P., Antonia, S.J., Massard, C., Zandberg, D.P., Maher, C., Khleif, S., Jin, X., Rebelatto, M., Steele, K., Antal, J., Gupta, A., Spreafico, A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
Mok, T., Camidge, D.R., Gadgeel, S.M., Rosell, R., Dziadziuszko, R., Kim, D.-W., Pérol, M., Ou, S.-H.I., Ahn, J.S., Shaw, A.T., Bordogna, W., Smoljanović, V., Hilton, M., Ruf, T., Noé, J., Peters, S.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
Kim, H.R., Lim, S.M., Kim, H.J., Hwang, S.K., Park, J.K., Shin, E., Bae, M.K., Ou, S.-H.I., Wang, J., Jewell, S.S., Kang, D.R., Soo, R.A., Haack, H., Kim, J.H., Shim, H.S., Cho, B.C.
Published in Annals of oncology (01.09.2013)
Published in Annals of oncology (01.09.2013)
Get full text
Journal Article
MA07.09 BBT-176, a 4th generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: PK, Safety and Efficacy from Phase 1 Study
Lim, S.M., Ahn, J.S., Hong, M.-H., Kim, T.M., Jung, H.-A., Ou, S.-H.I., Jeong, S., Lee, Y.-H., Yim, E., Jung, S., Lee, S.-Y., Kim, D.-W.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC)
Antonia, S.J., Brahmer, J.R., Khleif, S., Balmanoukian, A.S., Ou, S.-H.I., Gutierrez, M., Kim, D.-W., Kim, S.-W., Ahn, M.-J., Leach, J., Jamal, R., Jaeger, D., Jerusalem, G., Jin, X., Gupta, A., Antal, J., Segal, N.H.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Overall survival (OS) and updated safety from PROFILE 1001
Shaw, A., Riely, G.J., Bang, Y.-J., Kim, D.-W., Camidge, D.R., Shapiro, G.I., Usari, T., Wang, S.C., Wilner, K., Clark, J.W., Ou, S.-H.I.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): updated results from PROFILE 1001
Shaw, A., Riley, G.J., Bang, Y.-J., Kim, D.-W., Camidge, D.R., Varella-Garcia, M., Lafrate, A.J., Shapiro, G., Winter, M., Usari, T., Wang, S.C., Wilner, K., Clark, J.W., Ou, S.-H.I.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC)
Barlesi, F., Dingemans, A.-M.C., Yang, J.C.-H., Ou, S.-H.I., Ahn, J.S., De Petris, L., Hughes, B., Lena, H., Bordogna, W., Golding, S., Morcos, P.N., Balas, B., Zeaiter, A., Kim, D.-W.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations
Solomon, B.J., Martini, J.-F., Ou, S.-H.I., Chiari, R., Soo, R.A., Bearz, A., Li, S., Thurm, H., Lin, C.-C., Riely, G.J., Bauer, T.M., Shaw, A.T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Comprehensive Genomic Profiling (CGP) of 114,200 advanced cancers identifies recurrent Kinase Domain Duplications (KDD) and novel oncogenic fusions in diverse tumor types
Ikeda, S., Gay, L., Pavlick, D., Chung, J., Ramkissoon, S., Daniel, S., Elvin, J., Severson, E., Bivona, T., Reckamp, K., Klempner, S., Ou, S.-H.I., Schrock, A., Miller, V., Stephens, P., Ross, J., Ganesan, S., Lovly, C., Mansfield, A., Ali, S.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Kinase fusions in colorectal cancers: A unique biologic subset
Madison, R, Pietrantonio, F, Juckett, L, Cremolini, C, Chung, J, Albacker, L A, Miller, V A, Klempner, S J, Resnick, M B, Yakirevich, E, Ou, S-H I, Fakih, M, Schrock, A B, Ross, J S, Ali, S M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)
Crinò, L., Ahn, M.-J., Han, J.-Y., Liu, X., Ou, S.-H.I., Shaw, A.T., Yang, P.-C., Shi, Y.-K., Lanzalone, S., Polli, A., Wilner, K.D., Kim, D.-W.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Small cell lung carcinoma harbors targetable alterations including MYCL1 fusions responding to aurora kinase inhibitor
Ali, S., Kolla, B., Bailey, M., Schrock, A.B., Klempner, S.J., Frampton, G.M., Fabrizio, D.A., Ou, S.-H.I., He, J., Suh, J., Ross, J.S., Stephens, P., Miller, V., Patel, M.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article